Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 11Completed 3Recruiting 2Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1

Interventions

olaparib 1durvalumab 1apatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Small Cell Lung Carcinoma × apatinib × Clear all
NCT06773156 2025-01-14

Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer

Second Affiliated Hospital of Nanchang University

Phase 2 Enrolling by invitation
37 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡